Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori
Condition(s):Helicobacter Pylori InfectionLast Updated:April 24, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Helicobacter Pylori InfectionLast Updated:April 24, 2017Completed
Condition(s):Chronic Rhinosinusitis; Endoscopic Sinus SurgeryLast Updated:September 25, 2018Completed
Condition(s):Gastritis, Gastric Ulcer, and Duodenal UlcerLast Updated:February 11, 2014Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:May 2, 2018Completed
Condition(s):Pulmonary DiseasesLast Updated:August 23, 2006Completed
Condition(s):Helicobacter Pylori InfectionLast Updated:September 14, 2021Unknown status
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 4, 2011Completed
Condition(s):Dyspepsia; Peptic UlcerLast Updated:February 3, 2015Completed
Condition(s):Helicobacter Pylori InfectionLast Updated:July 11, 2018Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:November 24, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.